Medication-Induced Headache: Overview and Systematic Review of Therapeutic Approaches

Abstract

Spanish

French

OBJECTIVE:

To review medication-induced headache (MIH) through a systematic evaluation of the literature regarding the pharmacologic management of this condition.

METHODOLOGY:

To identify and evaluate all pharmacologic interventions for MIH, we conducted a qualitative systematic review of the English-language literature from 1966 to June 1998 using MEDLINE. The following search terms were used: chronic daily headache, transformed migraine, analgesic withdrawal headache, analgesic rebound headache, drug-associated headache, medication-induced headache, detoxification, and dihydroergotamine. In addition, a review of the references from relevant literature was also conducted to collect reports not identified in the MEDLINE search.

RESULTS:

Numerous therapies for acute management of MIH have been evaluated, although no rigorously conducted clinical trials were identified. Therapies evaluated include abrupt withdrawal of analgesics, initiation of dihydroergotamine, nonsteroidal antiinflammatory agents, methylergonovine, dihydroergotamine, sumatriptan, amitriptyline, dexamethasone, piracetam, prothipendyl, and valproate. Epidemiology, diagnosis, clinical features, pathophysiology, and long-term prognosis of therapy are discussed and therapeutic guidelines are offered.

CONCLUSIONS:

MIH is an underrecognized and difficult condition affecting headache-prone patients. The published literature concerning treatment of patients with MIH is scant and of poor quality, making it difficult for clinicians to decide on appropriate therapy. Recognition and treatment of MIH may lead to a long-term improvement in headache relief for many patients. It appears that complete withdrawal of the medications being overused is required for favorable long-term results.

Keywords

headache sumatriptan dihydroergotamine analgesics migraine

Get full access to this article

View all access options for this article.

References

Mathew

. Transformed migraine, analgesic rebound, and other chronic daily headaches. Neurol Clin 1997;15:167–86.

Saper

. Ergotamine dependency: A review. Headache 1987;27:435–8.

Saper

. Daily chronic headache. Neurol Clin 1990;8:891–901.

Mathew

. Drug-induced headache. Neurol Clin 1990;8:903–12.

Rapoport

. Analgesic rebound headache. Headache 1988;28:662–5.

Mathew

Stubits

Nigram

. Transformation of episodic migraine into daily headache: Analysis of factors. Headache 1982;22:66–8.

Mathew

Reuveni

Perez

. Transformed or evolutive migraine. Headache 1987;27:102–6.

Silberstein

Young

. Analgesic rebound headache: How great is the problem and what can be done? Drug Saf 1995;13:133–44.

Rasmussen

. Migraine and tension-type headache in the general population: Psychosocial factors. Int J Epidemiol 1992;21:1138–43.

10.

Wolfson

Graham

. Development of tolerance to ergot alkaloids in a patient with unusually severe migraine. N Engl J Med 1949;241:296–8.

11.

Rowsell

Neylan

Wilkinson

. Ergotamine induced headaches in migrainous patients. Headache 1973;13:65–7.

12.

Wainscott

Volans

Wilkinson

. Ergotamine-induced headache (letter). Br Med J 1974;2:724.

13.

Mathew

Kurman

Perez

. Drug induced refractory headache: Clinical features and management. Headache 1990;30:634–8.

14.

Pini

Trenti

. Does chronic use of sumatriptan induce dependence? Headache 1994;34:600.

15.

Catarci

Fiacco

Argentino

Sette

Cerbo

. Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 1994;14:374–5.

16.

Osborne

Austin

RCT

Dawson

Lange

. Is there a problem with long term use of sumatriptan in acute migraine (letter)? BMJ 1994;308:113.

17.

Gobel

Stolze

Heinze

Dworschak

. Easy therapeutic management of sumatriptan-induced daily headache. Neurology 1996;47:297–8.

18.

Edmeads

. Analgesic-induced headaches: An unrecognized epidemic. Headache 1990;30:614–5.

19.

Maizels

. The clinician's approach to the management of headache. West J Med 1998;168:203–12.

20.

Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(supp 7):1–96.

21.

Silberstein

Lipton

Sliwinski

. Classification of daily or near daily chronic daily headache: Field trial of revised HIS criteria. Neurology 1996;47:871–5.

22.

Silberstein

Lipton

Sliwinski

. Assessment for revised criteria of chronic daily headache (abstract). Neurology 1995;45:A394.

23.

Sandrini

Manzoni

Zanferrari

Nappi

. An epidemiological approach to the nosography of chronic daily headache. Cephalalgia 1993;13(suppl):72–7.

24.

Micieli

Manzoni

Granella

. Clinical and epidemiological observations on drug abuse in headache patients. In: Diener

Wilkinson

, eds. Drug induced headache. Berlin: Springer-Verlag, 1988:20–8.

25.

Diener

Tfelt-Hansen

. Headache associated with chronic use of substances. In: Olesen

Tfelt-Hansen

, eds. The headache. New York: Raven Press, 1993:721–7.

26.

Rapoport

Stang

Gutterman

Cady

Markley

Weeks

Analgesic rebound headache in clinical practice: Data from a physician survey. Headache 1995;36:14–9.

27.

Schnider

Aull

Baumgartner

Marterer

Wober

Zeiler

Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five year follow-up. Cephalalgia 1996;16:481–5.

28.

Silberstein

Lipton

. Chronic daily headache. In: Goadsby

Silberstein

, eds. Blue books of practical neurology. Newton MA: Butterworth-Heinemann, 1997:201–25.

29.

Hering

Glover

Patichis

Catarci

Steiner

. 5-HT in migraine patients with medication-induced headache. Cephalalgia 1993;13:410–2.

30.

Sicuteri

. Opioid receptor impairment: Underlying mechanisms in “pain diseases”? Cephalalgia 1981;1:77–82.

31.

Lance

Parkes

Wilkenson

. Does analgesic abuse cause headache de novo? Headache 1990;28:61.

32.

Srikiatkhachorn

Maneesri

Govitrapong

Kasantikul

. Derangement of serotonin system in migrainous patients with analgesic abuse headache: Clues from platelets. Headache 1998;38:43–9.

33.

Nicolodi

Del Bianco

Sicuteri

. Modulation of excitatory amino acids pathways: A possible therapeutic approach to chronic daily headache associated with analgesic drug abuse. Int J Clin Pharmacol Res 1997;17:97–100.

34.

Diener

Dichgans

Scholz

Geiselhart

Gerber

Bille

. Analgesic-induced chronic headache: Long-term results of withdrawal therapy. J Neurol 1989;236:9–14.

35.

Kudrow

. Paradoxical effects of frequent analgesic use. Adv Neurol 1982;33:335–41.

36.

Isler

. Migraine treatment as a cause of chronic migraine. In: Rose

, ed. Advances in migraine research and therapy. New York: Raven Press, 1982:159–64.

37.

Hering

Steiner

. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991;337:1442–3.

38.

Ala-Hurula

Myllyla

Hokkanen

Tolola

. Tolfenamic acid and ergotamine abuse. Headache 1981;21:240–3.

39.

Mathew

. Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 1987;27:130–3.

40.

Pini

Bigarelli

Vitale

Sternieri

. Headache associated with chronic use of analgesics: A therapeutic approach. Headache 1996;36: 433–9.

41.

Graff-Radford

Bittar

. The use of methylergonovine (Methergine) in the initial control of drug induced refractory headache. Headache 1993;33:390–3.

42.

Raskin

. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986;36:995–7.

43.

Silberstein

Schulman

Hopkins

M. McFadde

Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990;30:334–9.

44.

Sands

. A protocol for butalbital, aspirin and caffeine (BAC) detoxification in headache patients. Headache 1990;30:491–6.

45.

Diener

Haab

Peters

Reid

Dichgans

Pilgram

. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1991;31:205–9.

46.

Bonuccelli

Nuti

Lucetti

Pavese

Dell'Agnello

Muratorio

. Amitriptyline and dexamethasone combined treatment in drug-induced headache. Cephalalgia 1996;16:197–200.

47.

Baumgartner

Wessely

Bingol

Maly

Holzner

. Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989;29:510–4.

48.

Mathew

Ali

. Valproate in the treatment of persistent chronic daily headache. Headache 1991;31:71–4.

49.

Klapper

Stanton

. Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headache. Headache 1992;32:21–3.

50.

Robbins

Remmes

. Outpatient repetitive intravenous dihydroergotamine. Headache 1992;32:455–8.

51.

Saper

Silberstein

Lake

III Winters

. Double-blind trial of fluoxetine: Chronic daily headache and migraine. Headache 1994;34: 497–502.

52.

Foster

Bafaloukos

. Paroxetine in the treatment of chronic daily headache. Headache 1994;34:587–9.

53.

Langemark

Olesen

. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 1994;34:20–4.

54.

Vijayan

Spillane

. Valproic acid treatment of chronic daily headache. Headache 1995;35:540–3.

55.

Rapoport

Weeks

Sheftell

. The “analgesic washout period”: A critical variable evaluation in the evaluation of headache treatment efficacy. Neurology 1986;36:100–1.

56.

Ala-Hurula

Myllyla

Hokkanen

. Ergotamine abuse: Results of ergotamine discontinuation, with special reference to plasma concentrations. Cephalalgia 1982;2:189–95.

57.

Tfelt-Hansen

Krabbe

. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1981;1:29–32.

58.

Silberstein

. Chronic daily headache: Long-term prognosis following inpatient treatment with repetitive IV DHE. Headache 1992;32:439–45.